Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05302817 · ClinicalTrials.gov registry record · Phase 1
Functional Lung Avoidance Radiation Therapy Using Hyperpolarized Xenon-129 MRI
A Phase 1 study, sponsored by Xemed.
- Terminated
- Registry status
- Phase 1
- Development phase
- 9
- Enrollment target
NCT05302817 is a Phase 1 study that was terminated before completion, run by Xemed. The registered enrollment target is 9 participants.
The verdict
NCT05302817, a Phase 1 study, was terminated before completion, sponsored by Xemed.
- TERMINATED
- Registry status
- Phase 1
- Development phase
- 9 participants
- Enrollment target
Study Summary
Cancer radiation treatment plans that employ lung functional avoidance methods require 3D maps that differentiate regions of healthy lung function from regions of compromised tissue to deliver sufficient dose to the tumor while preserving as much functioning lung as possible. Hyperpolarized xenon-129 MRI can provide maps of ventilatory function and gas exchange to the bloodstream. Improving treatment plans based on this novel imaging modality could reduce risk or severity of radiation pneumonitis and improve post-treatment quality of life.
Interventions
- COMBINATION_PRODUCT Hyperpolarized xenon MRI
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 9 participants |
| Start Date | 2023-03-17 |
| Est. Completion | 2025-02-28 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05302817
The ClinicalTrials.gov registry entry for NCT05302817 describes a study currently listed as terminated, categorized as Phase 1. The registered enrollment target is 9 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Xemed, which has 5 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Hyperpolarized xenon MRI is the first listed.
NCT05302817 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05302817 about?
NCT05302817 is a clinical study titled "Functional Lung Avoidance Radiation Therapy Using Hyperpolarized Xenon-129 MRI". Cancer radiation treatment plans that employ lung functional avoidance methods require 3D maps that differentiate regions of healthy lung function from regions of compromised tissue to deliver sufficient dose to the tumor while preserving as much functioning lung as possible. Hyperpolarized xenon-12...
What is the current status of trial NCT05302817?
This trial is currently terminated. It is a Phase 1 study. The enrollment target is 9 participants. The study started on 2023-03-17. Estimated completion is 2025-02-28.
What interventions are being tested in trial NCT05302817?
The interventions under investigation include: Hyperpolarized xenon MRI (COMBINATION_PRODUCT).
Who is sponsoring clinical trial NCT05302817?
This trial is sponsored by Xemed, which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.